Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

9.9%

30 terminated/withdrawn out of 302 trials

Success Rate

82.1%

-4.4% vs industry average

Late-Stage Pipeline

14%

41 trials in Phase 3/4

Results Transparency

4%

6 of 138 completed trials have results

Key Signals

34 recruiting6 with results27 terminated

Enrollment Performance

Analytics

N/A
92(53.5%)
Phase 2
30(17.4%)
Phase 4
21(12.2%)
Phase 3
20(11.6%)
Phase 1
9(5.2%)
172Total
N/A(92)
Phase 2(30)
Phase 4(21)
Phase 3(20)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (302)

Showing 20 of 302 trials
NCT07568093Not ApplicableRecruiting

PARO-agitation-study

Role: lead

NCT06931938Not ApplicableRecruiting

Awake Prone Positioning in Spontaneous Breathing Patients With Acute Hypoxic Respiratory Failure Due to Pneumonia

Role: collaborator

NCT06576934Not ApplicableRecruiting

Early TIPS in Patients With Liver Cirrhosis and Ascites

Role: collaborator

NCT03469609Not ApplicableRecruiting

Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("MUC-FIRE" Trial)

Role: collaborator

NCT06713837Phase 3Recruiting

IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.

Role: collaborator

NCT07242807Not Yet Recruiting

Minimally Invasive Prostate Interventions Registry (MIST Study)

Role: collaborator

NCT06795516Terminated

Observational Study on the Clinical Use of ex Vivo Lung Perfusion (XPS™) for Lung Transplantation

Role: lead

NCT03798860Completed

Monitoring of Donor-specific Antibodies After Treatment With Immunoglobulins, Plasmapheresis and Rituximab in Lung Transplantation

Role: lead

NCT06459024Recruiting

Master Framework For Relapse or Refractory Acute Myeloid Leukemia

Role: collaborator

NCT06042751Not ApplicableActive Not Recruiting

Psychosomatic, Physical Activity or Both for Post-covid19 Syndrom

Role: lead

NCT05635864Completed

Impact of Catheter Ablation on ABC Risk Scores

Role: lead

NCT06603311Not ApplicableActive Not Recruiting

Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection

Role: lead

NCT04732910Recruiting

Modulate-CF: Cystic Fibrosis Transmembrane Regulator (CFTR) Biomarker Study to Evaluate the Rescue of Mutant CFTR in Patients With Cystic Fibrosis Treated With CFTR-modulators

Role: collaborator

NCT04522544Phase 2Recruiting

Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC

Role: collaborator

NCT06990087Phase 2Recruiting

T-cell Therapy in Patients With PML

Role: lead

NCT06545175Phase 1Recruiting

Intracochlear Application of VSF1.01 for the Reduction of Cochlear Implant Surgery Related Trauma

Role: lead

NCT07396038Not Yet Recruiting

INTRAOPERATIVE BLADDER INJURY ASSESSMENT IN TURBT USING BICEP

Role: collaborator

NCT07384039Not ApplicableNot Yet Recruiting

Exercise Training in Patients With Myeloproliferative Neoplasms

Role: lead

NCT07008729Not ApplicableActive Not Recruiting

Heart Failure Patient Management and Interventions Using Continuous Patient Monitoring Outside Hospitals and Real-world Data

Role: collaborator

NCT07378202Active Not Recruiting

Machine Learning for Prediction of Therapy Response in Autoimmune Hepatitis

Role: lead